Read this commentary to gain expert perspective on the role of immunotherapy for patients with extensive-stage SCLC.
Here are my thoughts on a few studies presented at ASCO 2019 with the potential to impact SCLC care in the near future.
Review this CME-certified activity to get up to date on the most recent clinical data informing optimal management of patients with SCLC.
Download this slideset to review the latest clinical data guiding optimal care of patients with SCLC in 2019.
Watch this CME-certified video module of 2 lung cancer experts discussing recent advances in immunotherapy for the treatment of SCLC as they apply to a series of patient cases.
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA
Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.